Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Celularity (CELU) Accumulated Expenses (2020 - 2025)

Celularity (CELU) has disclosed Accumulated Expenses for 6 consecutive years, with $29.4 million as the latest value for Q3 2025.

  • On a quarterly basis, Accumulated Expenses rose 103.38% to $29.4 million in Q3 2025 year-over-year; TTM through Sep 2025 was $29.4 million, a 103.38% increase, with the full-year FY2024 number at $19.8 million, up 161.77% from a year prior.
  • Accumulated Expenses was $29.4 million for Q3 2025 at Celularity, down from $33.4 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $33.4 million in Q2 2025 to a low of $7.6 million in Q4 2023.
  • A 5-year average of $15.8 million and a median of $13.4 million in 2022 define the central range for Accumulated Expenses.
  • Peak YoY movement for Accumulated Expenses: tumbled 54.1% in 2023, then skyrocketed 221.35% in 2025.
  • Celularity's Accumulated Expenses stood at $11.7 million in 2021, then dropped by 22.23% to $9.1 million in 2022, then decreased by 16.42% to $7.6 million in 2023, then soared by 161.77% to $19.8 million in 2024, then soared by 48.28% to $29.4 million in 2025.
  • Per Business Quant, the three most recent readings for CELU's Accumulated Expenses are $29.4 million (Q3 2025), $33.4 million (Q2 2025), and $25.2 million (Q1 2025).